Medication effects on the gut microbiome in allo-HCT
- PMID: 37295398
- DOI: 10.1016/j.cell.2023.04.011
Medication effects on the gut microbiome in allo-HCT
Abstract
Decreased gut microbiome diversity has been associated with negative outcome in allogeneic hematopoietic stem cell transfer (HCT). A study published in this issue of Cell identifies associations between non-antibiotic drug administration, microbiome state transitions, and response to HCT, highlighting the potential impact of such drugs on microbiome and HCT outcome.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients.Cell. 2023 Jun 8;186(12):2705-2718.e17. doi: 10.1016/j.cell.2023.05.007. Epub 2023 Jun 8. Cell. 2023. PMID: 37295406 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
